OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - MONTE ROSA THERAPEUTICS INC ownership

MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 68 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of MONTE ROSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$409,440
-40.5%
85,478
-14.9%
0.01%
-54.5%
Q2 2023$688,274
-7.5%
100,478
+5.2%
0.02%
-4.3%
Q1 2023$744,163
-99.9%
95,528
+4.3%
0.02%
+64.3%
Q3 2022$748,000,000
-23.9%
91,615
-9.9%
0.01%0.0%
Q2 2022$983,000,000101,6470.01%
Other shareholders
MONTE ROSA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,472,331$11,204,4397.40%
NEA Management Company, LLC 7,692,298$58,538,3883.29%
Cormorant Asset Management, LP 2,893,717$22,0211.47%
Alphabet Inc. 1,464,015$11,141,1540.65%
Avoro Capital Advisors LLC 4,325,000$32,913,2500.49%
Casdin Capital, LLC 510,882$3,887,8120.30%
RTW INVESTMENTS, LP 1,214,572$9,242,8930.19%
Virtus Investment Advisers, Inc. 12,638$96,1750.06%
Woodline Partners LP 511,351$3,891,3810.05%
CORNERCAP INVESTMENT COUNSEL INC 28,192$214,5410.04%
View complete list of MONTE ROSA THERAPEUTICS INC shareholders